Biocon, a leading biopharmaceutical company, has made a significant move by transferring its India’s branded formulations business to Eris Lifesciences for a whopping ₹1,242 crore on a slump sale basis. This strategic decision is expected to streamline Biocon’s operations and further strengthen Eris Lifesciences’ presence in the market.
In another exciting development, Ashiana, a prominent real estate developer, has announced that all units in phase 3 of ‘Ashiana Amarah’ have been converted into bookings by March 30, with a sale value of 4.40 billion rupees. This achievement reflects the strong demand for Ashiana’s projects and underscores the company’s commitment to delivering quality homes to its customers.
Meanwhile, Ramco Cements has successfully commissioned line II at its grinding unit in Odisha, enhancing its production capacity and operational efficiency. This expansion is poised to boost Ramco Cements’ market presence and meet the growing demand for cement in the region.
ESAF Small Finance Bank has taken a significant step by operationalizing its authorized dealer category 1 license for Foreign Exchange Operations, effective April 2. This move is expected to enhance ESAF SFB’s offerings and provide customers with a wider range of financial services.
Sunteck Realty has secured a long-term rental agreement with BennettColeman & Co for its building in the prestigious Bandra Kurla Complex (BKC) in Mumbai. This collaboration is a testament to Sunteck Realty’s premium offerings and strong presence in the commercial real estate sector.
These developments in the business world highlight the dynamic and evolving nature of the market, with companies making strategic moves to enhance their operations and drive growth. Stay tuned for more updates on the latest developments in the corporate landscape.
